Empower Pharmacy
Empower Pharmacy is a 503A compounding pharmacy and a 503B outsourcing facility based in Houston, TX, with 1 more site. A government record names semaglutide and tirzepatide at Empower Pharmacy; the newest is an FDA warning letter dated September 18, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from Empower Pharmacy without a prescription from a licensed clinician.12
How to get a GLP‑1 filled by Empower PharmacyChecked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.
Empower Pharmacy at a glance
How to get a GLP‑1 filled by Empower Pharmacy
To get a GLP‑1 from Empower Pharmacy, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.
These are the three programs ranked highest on our score. Check that a program ships to your state before you sign up.
- 1Health questionnaire, online
- 2A licensed clinician decides
- 3The pharmacy ships to you
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Prefer your own clinician? You’re free to: ask them to send your prescription to Empower Pharmacy or another licensed pharmacy.
See every program we rankWhat ties Empower Pharmacy to GLP‑1s
- Its own siteNovember 18, 2026 · semaglutide and tirzepatideLists a GLP-1 product on its own site5
“Semaglutide and tirzepatide as B12 and niacinamide combination injections, or as oral dissolvable tablets”
- FDA warning letterSeptember 18, 2026 · semaglutide and tirzepatideFDA warning letter WL # 738238 to Empower Clinic Services, LLC6
“which appear to be essentially copies of FDA-approved semaglutide and tirzepatide products.”
- Court recordApril 29, 2026 · tirzepatideEli Lilly and Company v. Empower Clinic Services, LLC d/b/a Empower Pharmacy, memorandum opinion and order7
“Empower makes and sells two versions of tirzepatide medications: Tirzepatide ODT, dissolving tablets taken orally; and injections containing fixed-dose combinations of tirzepatide and niacinamide”
- FDA inspection report (Form 483)November 14, 2025 · semaglutideFDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2025-11-148
“Semaglutide / Cyanocobalamin (2.5 ML) 5/0.5 MG/ML”
- FDA inspection report (Form 483)November 14, 2025 · tirzepatideFDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2025-11-149
“Tirzepatide /Niacinamide Injection 8/2 mg/mL, Lot 218493”
- Court recordApril 11, 2025Empower Clinic Services, L.L.C. v. LegitScript L.L.C., opinion and order on motion to seal10
“Empower alleges that it sells glucagon- like peptide 1 receptor agonists (“GLP-1”) medications at a lower cost”
- FDA inspection report (Form 483)October 4, 2024 · semaglutide and tirzepatideFDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2024-10-0411
“during the aseptic filling of Semaglutide/Cyanocobalmin (2.5ml)”
Empower Pharmacy’s FDA record
| Date | What the FDA did |
|---|---|
| September 18, 2026 | Warning Letter Issued 09/18/20266 |
| November 14, 2025 | 483 Issued 11/14/20259 |
| November 14, 2025 | 483 Issued 11/14/20258 |
| April 2, 2025 | Warning Letter Issued 04/02/202512 |
| April 2, 2025 | Warning Letter Issued 04/02/202513 |
| October 4, 2024 | 483 Issued 10/04/202414 |
| August 28, 2024 | 483 Issued 08/28/202415 |
| December 1, 2023 | 483 Issued 12/01/202316 |
| May 4, 2023 | Regulatory Meeting Held 05/04/2023 |
| August 5, 2022 | 483 Issued 08/05/202217 |
| October 15, 2021 | Warning Letter (10/15/2021)18 |
| March 6, 2020 | 483 Issued 03/06/202019 |
| July 22, 2019 | Untitled Letter Issued 07/22/201920 |
| April 2, 2019 | FMD-145 Letter Issued 04/02/201921 |
Empower Pharmacy’s 2 sites
| Site | NPI |
|---|---|
| Empower Pharmacy7601 N Sam Houston Pkwy W Ste 200, Houston, TX | 12852763111730449299 |
| Empower Clinic Services New JerseyEast Windsor, NJ | — |
What a compounded GLP‑1 is, and what it isn’t
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.2728 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.2622
Empower Pharmacy: questions
- 1.Empower Pharmacy: what it says it isempowerpharmacy.comretrieved 2026-11-20↩“Empower Pharmacy is the nation's premier 503A compounding pharmacy and 503B outsourcing facility.”
- 2.NPI Registry: EMPOWER PHARMACY (NPI 1285276311)Centers for Medicare & Medicaid Servicesretrieved 2026-11-20↩
- 3.NPI Registry: EMPOWER PHARMACY (NPI 1730449299)Centers for Medicare & Medicaid Servicesretrieved 2026-11-20
- 4.Registered Outsourcing FacilitiesU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 5.Lists a GLP-1 product on its own siteEmpower Pharmacyretrieved 2026-11-18↩“Semaglutide and tirzepatide as B12 and niacinamide combination injections, or as oral dissolvable tablets”
- 6.FDA warning letter WL # 738238 to Empower Clinic Services, LLCFDAretrieved 2026-09-18↩“which appear to be essentially copies of FDA-approved semaglutide and tirzepatide products.”
- 7.Eli Lilly and Company v. Empower Clinic Services, LLC d/b/a Empower Pharmacy, memorandum opinion and orderU.S. District Court for the Southern District of Texasretrieved 2026-04-29↩“Empower makes and sells two versions of tirzepatide medications: Tirzepatide ODT, dissolving tablets taken orally; and injections containing fixed-dose combinations of tirzepatide and niacinamide”
- 8.FDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2025-11-14FDAretrieved 2025-11-14↩“Semaglutide / Cyanocobalamin (2.5 ML) 5/0.5 MG/ML”
- 9.FDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2025-11-14FDAretrieved 2025-11-14↩“Tirzepatide /Niacinamide Injection 8/2 mg/mL, Lot 218493”
- 10.Empower Clinic Services, L.L.C. v. LegitScript L.L.C., opinion and order on motion to sealU.S. District Court for the District of Oregonretrieved 2025-04-11↩“Empower alleges that it sells glucagon- like peptide 1 receptor agonists (“GLP-1”) medications at a lower cost”
- 11.FDA Form 483 inspectional observations, Empower Clinic Services, LLC, issued 2024-10-04FDAretrieved 2024-10-04↩“during the aseptic filling of Semaglutide/Cyanocobalmin (2.5ml)”
- 12.FDA: Warning Letter Issued 04/02/2025U.S. Food and Drug Administration↩
- 13.FDA: Warning Letter Issued 04/02/2025U.S. Food and Drug Administration↩
- 14.FDA: 483 Issued 10/04/2024 (PDF - 5 MB)U.S. Food and Drug Administration↩
- 15.FDA: 483 Issued 08/28/2024 (PDF - 2.25MB)U.S. Food and Drug Administration↩
- 16.FDA: 483 Issued 12/01/2023 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 17.FDA: 483 Issued 08/05/2022 (PDF - 20.4MB)U.S. Food and Drug Administration↩
- 18.FDA: Warning Letter (10/15/2021)U.S. Food and Drug Administration↩
- 19.FDA: 483 Issued 03/06/2020 (PDF - 1.02MB)U.S. Food and Drug Administration↩
- 20.FDA: Untitled Letter Issued 07/22/2019 (PDF - 106KB)U.S. Food and Drug Administration↩
- 21.FDA: FMD-145 Letter Issued 04/02/2019 (PDF - 51KB)U.S. Food and Drug Administration↩
- 22.Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 23.ACHC/PCAB: accreditation directoryorganization.achc.orgretrieved 2026-11-18↩
- 24.LegitScript: accreditation directorylegitscript.comretrieved 2026-11-18↩
- 25.Empower Pharmacy: where it shipsempowerpharmacy.comretrieved 2026-11-20↩“we're licensed to ship in most states, including Puerto Rico.”
- 26.Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
- 27.
- 28.
A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.